Analysis Asks: Are GLP-1 Drugs Safe in People With Frailty?

This Medical News article discusses an analysis of cardiovascular benefits and safety of semaglutide use in trial participants with frailty, defined by accumulated age-related health deficits.

Authors

Institutions

Publication Details

Journal
JAMA
Published
2026-10-30
DOI
https://doi.org/10.1001/jama.2026.22482
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Analysis Asks: Are GLP-1 Drugs Safe in People With Frailty?

Anna Bock
3 links
JAMA
Diabetes Treatment and Management
article

Analysis Asks: Are GLP-1 Drugs Safe in People With Frailty?

Anna Bock
article en

Abstract

This Medical News article discusses an analysis of cardiovascular benefits and safety of semaglutide use in trial participants with frailty, defined by accumulated age-related health deficits.

JAMA
Northwestern University (US)
Good health and well-being
Openalex Percentile: Top 11%
Diabetes Treatment and Management
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Analysis Asks: Are GLP-1 Drugs Safe in People With Frailty? — Anna Bock · JAMA (2026) | TGRS Research Map | TGRS